Revised Annual Report 2024-25 under Regulation 34 (1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
UFLEX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Uflex Ltd has submitted a revised version of its Annual Report for FY 2024-25 to BSE and NSE, correcting an earlier version filed on July 15, 2025. The revised report has been uploaded to the company's website. For FY 2024-25, Uflex reported consolidated net total income of Rs 1,51,838 million, up 12.4% year-on-year, driven by an 8% increase in sales volumes to 6,47,499 metric tonnes. Operational EBITDA grew 18.1% to Rs 19,024 million, while consolidated PAT stood at Rs 1,423 million. The packaging films segment saw a 10.4% jump in production volumes. The company is investing Rs 317 crore in recycling capacity and expanding aseptic packaging globally, with new facilities in Egypt and Mexico.
The revision appears to be a correction rather than a material restatement, so impact is limited. The underlying results are positive — double-digit revenue growth, strong EBITDA expansion outpacing revenue, and continued capacity expansion. Shareholders should note the strong operational momentum, though PAT of Rs 1,423 million remains modest relative to revenue scale, indicating margin pressure at the net level.